Please use this identifier to cite or link to this item:
Title: Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
Authors: Kelly, DJ
Gershlick, T
Witzenbichler, B
Guagliumi, G
Fahy, M
Dangas, G
Mehran, R
Stone, GW
First Published: Oct-2011
Citation: AM HEART J, 2011, 162 (4), pp. 663-670
Abstract: Congestive heart failure (CHF) is a major source of morbidity, mortality, and health-care resource consumption. However, the incidence of symptomatic CHF after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has rarely been fully reported. We therefore examined the early and late incidence, predictors, and implications of CHF in the large-scale, prospective, randomized HORIZONS-AMI trial.
DOI Link: 10.1016/j.ahj.2011.08.002
eISSN: 1097-6744
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.